Urocortin II Treatment Reduces Skeletal Muscle Mass and Function Loss during Atrophy and Increases Nonatrophying Skeletal Muscle Mass and Function

Endocrinology

Volumn 144, Issue 11, 2003, Pages 4939-4946

  Hinkle, Richard T ^a   Donnelly, Elizabeth ^a   Cody, David B ^a   Bauer, Mary Beth ^a   Isfort, Robert J ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2; UROCORTIN III;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE MASS; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADRENAL CORTEX HORMONES; ANIMALS; CASTS, SURGICAL; CHO CELLS; CORTICOTROPIN-RELEASING HORMONE; CRICETINAE; HYPERTROPHY; LIGANDS; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SCIATIC NERVE; WOUNDS AND INJURIES;

EID: 0242552039     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0271     Document Type: Article

References (29)

1. Owens MJ, Nemeroff CB 1991 Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
2. McCarthy JR, Heinrichs SC, Grigoriadis DE 1999 Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 5:289-315
3. Dautzenberg FM, Hauger RL 2002 The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77
4. De Souza EB 1995 Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20:789-819
5. Perrin MH, Vale WW 1999 Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885:312-328
6. Eckart K, Radulovic J, Radulovic M, Jahn O, Blank T, Stiedl O, Spiess J 1999 Actions of CRF and its analogs. Curr Med Chem 6:1035-1053
7. Koob GF, Heinrichs SC 1999 A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848:141-152
8. Turnbull AV, Rivier C 1997 Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding proteins, and related peptides. Proc Soc Exp Biol Med 215:1-10
9. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF 1998 Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102
10. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W 1998 Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162-166
11. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, Lee KF 2002 Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 99:7734-7739
12. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP 2000 Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin- releasing hormone receptor 2. Nat Genet 24:403-409
13. Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J 2000 Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24: 415-419
14. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW 2001 Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848
15. Hsu SY, Hsueh AJ 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605-611
16. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW 2001 Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575
17. Chen A, Vaughan J, Vale WW, Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin releasing factor receptor pathways. Mol Endocrinol, in press
18. Miampamba M, Maillot C, Million M, Tache Y 2002 Peripheral CRF activates myenteric neurons in the proximal colon through CRF(1) receptor in conscious rats. Am J Physiol Gastrointest Liver Physiol 282:G857-G865
19. McAlexander MA, Undem BJ 1997 Enhancement of tachykinin-induced contractions of guinea pig isolated bronchus by corticotropin-releasing factor. Neuropeptides 31:293-299
20. Heymann-Monnikes I, Tache Y, Trauner M, Weiner H, Garrick T 1991 CRF microinjected into the dorsal vagal complex inhibits TRH analog-and kainic acid-stimulated gastric contractility in rats. Brain Res 554:139-144
21. Tamaoki J, Sakai N, Kobayashi K, Kanemura T, Shibasaki T, Takizawa T 1998 Corticotropin-releasing factor potentiates the contractile response of rabbit airway smooth muscle to electrical field stimulation but not to acetylcholine. Am Rev Respir Dis 140:1331-1335
22. Garzon J, Hollt V, Schulz R, Herz A 1985 Excitatory neuropeptides activate opioid mechanisms in the guinea pig ileum. Neuropeptides 5:583-586
23. Kihara N, Fujimura M, Yamamoto I, Itoh E, Inui A, Fujimiya M 2001 Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am J Physiol Gastrointest Liver Physiol 280:G406-G419
24. Grill HJ, Markison S, Ginsberg A, Kaplan JM 2000 Long-term effects on feeding and body weight after stimulation of forebrain or hindbrain CRH receptors with urocortin. Brain Res 867:19-28
25. Wang L, Martinez V, Vale W, Tache Y 2000 Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats. Brain Res 855:47-57
26. Heldwein KA, Duncan JE, Stenzel P, Rittenberg MB, Stenzel-Poore MP 1997 Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Mol Cell Endocrinol 131:167-172
27. Lovenberg TW, Chalmers DT, Liu C, De Souza EB 1995 CRF2 α and CRF2 β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142
28. Kishimoto T, Pearse RN, Lin CR, Rosenfeld MG 1995 A sauvagine/ corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112
29. Hinkle RT, Donnelly E, Cody DB, Samuelsson S, Lange JS, Bauer MB, Tarnopolsky M, Sheldon RJ, Coste SC, Tobar E, Stenzel-Poore MP, Isfort RJ, Activation of the corticotropin releasing factor 2 receptor modulates skeletal muscle mass under physiological and pathological conditions. Am J Physiol, in press